Please login to the form below

Not currently logged in
Email:
Password:

ABPI

This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

Daily Brief: AI to boost early NHS cancer diagnosis, AZ shareholder revolt, Juluca approval

Mike Thompson, chief executive of the UK pharma industry body the ABPI, said:.

Latest news

More from news
Approximately 87 fully matching, plus 502 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Stevens was the star turn at the ABPI’s annual conference in London in late April, and skilfully balanced talk of greater NHS-pharma partnership with warnings of a tough line ... Both the ABPI’s chief executive Mike Thompson and Simon Stevens wanted

  • Data visualisation in medical communications Data visualisation in medical communications

    3. Accuracy - maintain scientific rigour. As per the ABPI guidelines, data must be presented in a clear, fair and balanced way.

  • Leo has its eyes on the prize Leo has its eyes on the prize

    The ABPI’s Dermatology Initiative wants treatment of the condition to become ‘an exemplar for integration, self-care and harnessing technology and innovation’. ... The ABPI’s dermatology report recorded that 85% of patients with skin conditions

  • Shaping healthcare Shaping healthcare

    We, as EMG, feed into the ABPI’s negotiations with the government on the next PPRS agreement.

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Life science companies, the ABPI and EFPIA have been clear that the UK and the EU need to provide businesses with ‘certainty’so that they are able to create contingency plans

More from intelligence
Approximately 6 fully matching, plus 33 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    His career history has seen him work in private equity and venture capital and he has been president of the ABPI.

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    Professor Carole Longson moves from NICE to the ABPI. She joins the UK pharma body as its chief scientific officer. ... Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at

  • HCA appoints Mike Dixon as its new CEO HCA appoints Mike Dixon as its new CEO

    Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    AZ's Lisa Anson elected president of ABPI. She takes up the lead role from April 2017. ... Speaking on behalf of the board and all staff at the ABPI, we very much look forward to working with Lisa.”.

  • ABPI appoints Mike Thompson as chief executive ABPI appoints Mike Thompson as chief executive

    ABPI appoints Mike Thompson as chief executive. He replaces acting chief executive officer Alison Clough. ... The Association of the British Pharmaceutical Industry (ABPI) has named Mike Thompson as its new chief executive, who will replace Alison Clough

More from appointments
Approximately 21 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics